Metabolic Dysfunction in Continuous‐Flow Left Ventricular Assist Devices Patients and Outcomes

Metabolic Dysfunction in Continuous‐Flow Left Ventricular Assist Devices Patients and Outcomes

Background Metabolic impairment is common in heart failure patients. Continuous‐flow left ventricular assist devices (CF‐LVADs) improve hemodynamics and outcomes in patients with advanced heart failure; however, the effect of CF‐LVADs on metabolic status is unknown. This study aims to evaluate the c...

Full description

Bibliographic Details
Main Authors: Ann B. Nguyen, Teruhiko Imamura, Stephanie Besser, Daniel Rodgers, Ben Chung, Jayant Raikhelkar, Sara Kalantari, Bryan Smith, Nitasha Sarswat, Colleen LaBuhn, Valluvan Jeevanandam, Gene Kim, Gabriel Sayer, Nir Uriel
Format: Article
Language:English
Published: Wiley 2019-11-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
diabetes mellitus
heart failure
left ventricular assist device
testosterone
thyroid hormones
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.013278

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.119.013278

Similar Items